SCHIZOPHRENIA, ACUTE EPISODE

Clinical trials for SCHIZOPHRENIA, ACUTE EPISODE explained in plain language.

Never miss a new study

Get alerted when new SCHIZOPHRENIA, ACUTE EPISODE trials appear

Sign up with your email to follow new studies for SCHIZOPHRENIA, ACUTE EPISODE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New schizophrenia drug shows promise in early trial

Symptom relief Completed

This study tested a new drug called MK-8189 (elpipodect) in 224 adults experiencing an acute episode of schizophrenia. Participants received either MK-8189, a placebo, or an active control drug (risperidone) for 4 weeks. The main goal was to see if MK-8189 reduces schizophrenia s…

Matched conditions: SCHIZOPHRENIA, ACUTE EPISODE

Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief

Last updated May 17, 2026 04:11 UTC

SCHIZOPHRENIA, ACUTE EPISODE

Get alerted when new SCHIZOPHRENIA, ACUTE EPISODE trials appear

New schizophrenia drug shows promise in early trial